On May 20, 2022, Quest Diagnostics Incorporated announced that at its annual general meeting of shareholders held on May 18, 2022, the stockholder proposal regarding the right to call special meetings of stockholders was not approved.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
137.6 USD | -0.46% | +0.62% | -0.24% |
05-01 | Quest Diagnostics to Acquire PathAI Diagnostics Assets in Collaboration Deal | MT |
04-30 | Baird Adjusts Quest Diagnostics' Price Target to $144 From $138 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.24% | 15.35B | |
-28.69% | 85.35B | |
+14.32% | 81.95B | |
+9.37% | 28.99B | |
-11.43% | 16.98B | |
-0.36% | 16.85B | |
+4.32% | 12.42B | |
+33.40% | 12.19B | |
-31.40% | 11.89B | |
-2.34% | 11.88B |
- Stock Market
- Equities
- DGX Stock
- News Quest Diagnostics Incorporated
- Declaration of Voting Results by Quest Diagnostics Incorporated